Efficient Strategies to Reduce Wait Time Between Diagnosis of Hidradenitis Suppurativa and Treatment

Panelists discuss the challenges of biologic access in hidradenitis suppurativa due to utilization management policies like step therapy, emphasizing the need for patient education, strategic planning, and leveraging resources—including clinical trials—to improve timely treatment and outcomes.